<p>This section provides information about the protein and gene name(s) and synonym(s) and about the organism that is the source of the protein sequence.<p><a href='/help/names_and_taxonomy_section' target='_top'>More...</a></p>Detailed information on MDP26698
Description |
Cyclin-C (Fragment) |
Sequence | MAGNFWQSSHYPKRRDHFALLKSLEQSWSFLSGKGNECGRQDNSGKTNEKIMKGHCLSLQWILDKQDLLKERQKDLKFLSEEEYWKLQIFFTNVIQALGEHLKLRQQVIATATVYFKRFYARYSLKSIDPVLMAPTCVFLASKVEEFGVVSNTRLIAAATSVLKTRFSYAFPKEFPYRMNHILECEFYLLEL |
Length | 192 |
Position | Kinase |
Organism | Homo sapiens (Human) |
Kingdom | Metazoa |
Lineage | Eukaryota> Metazoa> Chordata> Craniata> Vertebrata> Euteleostomi> Mammalia>
Eutheria> Euarchontoglires> Primates> Haplorrhini> Catarrhini> Hominidae>
Homo.
|
Aromaticity | 0.14 |
Grand average of hydropathy | -0.293 |
Instability index | 49.22 |
Isoelectric point | 9.21 |
Molecular weight | 22493.78 |
Publications | PubMed=14574404
PubMed=19369195
|
Function
Annotated function |
|
GO - Cellular Component | mediator complex GO:0016592 IEA:InterPro
|
GO - Biological Function | cyclin-dependent protein serine/threonine kinase regulator activity GO:0016538 IEA:InterPro
|
GO - Biological Process | regulation of transcription by RNA polymerase II GO:0006357 IEA:InterPro
|
Interaction
Repeat regions
Repeats |
>MDP26698
---------------------------------------------------------------------------
No. of Repeats|Total Score|Length |Diagonal| BW-From| BW-To| Level
2| 91.41| 31| 46| 89| 121| 1
---------------------------------------------------------------------------
89- 121 (49.16/39.19) IFFTNVIQALGEHLKLRqqVIATATVYFK.RF.YA
138- 170 (42.25/27.20) VFLASKVEEFGVVSNTR..LIAAATSVLKtRFsYA
---------------------------------------------------------------------------
---------------------------------------------------------------------------
No. of Repeats|Total Score|Length |Diagonal| BW-From| BW-To| Level
2| 59.10| 17| 46| 16| 32| 2
---------------------------------------------------------------------------
16- 32 (30.54/19.91) DHFALLKSLEQSWSFLS
64- 80 (28.56/18.21) DKQDLLKERQKDLKFLS
---------------------------------------------------------------------------
|
Associated diseases